Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
01 1Centrient Pharmaceuticals
02 6Dr. Reddy's Laboratories
03 1ALP Pharm
04 1Amoli Organics
05 1Apotex Pharmachem
06 2Arch Pharmalabs
07 1Asymchem Laboratories
08 1Aurobindo Pharma Limited
09 3Biocon
10 2Cadila Pharmaceuticals
11 1Changzhou Pharmaceutical Factory
12 1Chromo Laboratories
13 1EPHAR BIOLOGICAL AND CHEMICAL CO LTD
14 1HEC Pharm
15 2Hetero Drugs
16 1Ind Swift Laboratories Limited
17 2Jiangsu Alpha Pharmaceutical Co., Ltd.
18 1Jubilant Generics
19 1Laurus Labs
20 1Lek Pharmaceuticals
21 3Lupin Ltd
22 3MSN Laboratories
23 2Macleods Pharmaceuticals Limited
24 2Mankind Pharma
25 3Morepen Laboratories
26 1Par Pharmaceutical
27 1Pfizer Inc
28 3RANBAXY LABORATORIES LIMITED
29 1Raks Pharma
30 1Sandoz B2B
31 1Signa S.A. de C.V.
32 1Sun Pharmaceutical Industries Limited
33 5Teva API
34 1Torrent Pharmaceuticals Limited
35 1Viatris
36 1Vijayasri Organics Limited
37 1Zhejiang Haisen Pharmaceutical Co., Ltd.
38 1Zhejiang Hisun Pharmaceutical
39 1Zhejiang Jiangbei Pharmaceutical
40 3Zhejiang Neo-Dankong Pharm. Co.,Ltd.
41 4Zydus Lifesciences
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
GDUFA
DMF Review : Complete
Rev. Date : 2016-05-31
Pay. Date : 2015-08-20
DMF Number : 29520
Submission : 2015-08-03
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-27
Pay. Date : 2013-02-05
DMF Number : 18468
Submission : 2005-06-29
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-27
Pay. Date : 2013-01-04
DMF Number : 19997
Submission : 2006-11-27
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2020-02-20
Pay. Date : 2020-01-28
DMF Number : 34423
Submission : 2019-12-31
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25902
Submission : 2012-03-23
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-07
Pay. Date : 2013-09-25
DMF Number : 23664
Submission : 2010-03-30
Status :
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-27
Pay. Date : 2013-02-06
DMF Number : 21125
Submission : 2007-12-14
Status :
Type : II
We have 41 companies offering atorvastatin calcium anhydrous
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
